1 / 12

Apo C-III modulates VLDL

Size and apolipoprotein composition are the main factors determining atherogenicity of triglyceride-rich particles. Size and apolipoprotein composition are the main factors determining atherogenicity of triglyceride-rich particles. Apo C-III modulates VLDL.

lola
Télécharger la présentation

Apo C-III modulates VLDL

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Size and apolipoprotein composition are the main factors determining atherogenicity of triglyceride-rich particles

  2. Size and apolipoprotein composition are the main factors determining atherogenicity of triglyceride-rich particles

  3. Apo C-III modulates VLDL

  4. Apo C-III in apo B particles is atherogenic

  5. Relationship between apo C-III in apo Bcontaining lipoproteins and atherogenicity

  6. PROCAM StudyMI-Incidence according to LDL-cholesterol and triglycerides

  7. PROCAM StudyCHD risk according to LDL-C and TGincreased TG confers raised CHD risk at all levels of LDL-C

  8. HDL:an anti-atherogenic lipoprotein

  9. HDL metabolism:5 key genes

  10. HDL:apo AI-rich particles

  11. Apo A-I protects against atherosclerosis

  12. Apo A-II protects against atherosclerosisThe human apo A-II transgenic mouse model

More Related